Particle.news
Download on the App Store

Meningitis B Outbreak in Kent Climbs to 29 Cases as UK Expands Targeted Vaccination

Genomic testing is under way to assess whether the strain shows unusual transmissibility.

Overview

  • UKHSA now links 29 cases and two deaths to the Canterbury cluster, with the victims identified as an 18-year-old student and a 21-year-old University of Kent undergraduate.
  • Investigators trace likely exposure to Club Chemistry events held March 5–7, with antibiotic prophylaxis offered to attendees and University of Kent contacts.
  • Four vaccination centres are operating in Canterbury, with about 11,000 MenB doses allocated and more than 10,500 antibiotic courses and roughly 4,500 vaccines already distributed.
  • Scientists are analyzing patient samples to determine if bacterial changes contributed to the rapid spread, while close-contact behaviours such as sharing vape devices remain a potential driver.
  • ECDC and WHO assess risk to the wider EU/EEA public as very low, though one linked case has been reported in France and authorities urge vigilance and rapid local control; heavy demand has strained MenB vaccine supplies in some settings.